Home / Brands / The Compounding Pharmacy of America
The Compounding Pharmacy of America Recalls
383 recalls on record · September 23, 2015 to February 21, 2018 · Drugs
Recalls by year
15
18
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Sermorelin 300 mcg/ml + GHRP-2 300 mcg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, DO NOT SHAKE, The Compoundin
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Sermorelin 1000mcg/GHRP6 1000/GHRP2 1000 ml Injection, Multi-Dose Vial, Sterile, Refrigerate, DO NOT SHAKE, The Compou
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Sermorelin/GHRP6 1000/1000 mcg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, DO NOT SHAKE, The Compounding Pharma
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Sermorelin/GHRP2 1000/1000 mcg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, DO NOT SHAKE, The Compounding Pharma
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Sermorelin 1000 mcg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, DO NOT SHAKE, The Compounding Pharmacy of Ameri
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Selenium 200 mcg/ml Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxvil
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Pyridoxine Hydrochloride 100 mg/ml Injectable, Multi-Dose Vial, Sterile, Refrigerate, Protect from Light, The Compoundin
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Progesterone 100 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxv
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Polidocanol 5% Injection, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Polidocanol 1% Injection, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Phosphatidylcholine 0.1% Sodium Deoxycholate 0.089% Injection, Vial, Sterile, Refrigerate, The Compounding Pharmacy of A
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls PGE 80 (Alprostadil) 80 mcg/ml Injection, Multi-Dose Vial, Sterile, Keep Frozen, The Compounding Pharmacy of America, Kn
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls PGE 40 (Alprostadil) 40 mcg/ml Injection, ml, Multi-Dose Vial, Sterile, Keep Frozen, The Compounding Pharmacy of America
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls PGE 150 (Alprostadil) 150 mcg/ml, ml, Multi-Dose Vial, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxv
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Oxytocin 100 units/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville,
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Neomycin + Polymyxin B+ Bacitracin Ophthalmic Ointment, grams, Refrigerate, The Compounding Pharmacy of America, Knoxvil
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Nandrolone Decanoate 250 mg/ml Injection, ml Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Ame
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Nandrolone Decanoate 200 mg/ml Injection, ml Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Ame
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 70 mg/ml + Clonidine 1,100 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Kno
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 70 mg/ml + Bupivacaine 40 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxv
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 64 mg/ml + Bupivacaine 10 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxv
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 60 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 50 mg/ml +Fentanyl 1,000 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxv
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 50 mg/ml + Clonidine 200 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxv
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 50 mg/ml + Clonidine 100 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxv
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 50 mg/ml + Bupivacaine 2.5 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knox
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 50 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 45 mg/ml + Bupivacaine 40 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxv
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 45 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 42 mg/ml + Bupivacaine 8 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxvi
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility